US FDA Inspection at JNPC Facility, Visakhapatnam of Gland Pharma Ltd

Gland Pharma Ltd has announced that the United States Food and Drug Administration (US FDA) conducted an inspection at the Company's API Facility at JNPC, Visakhapatnam from 23rd January, 2023 to 27th January, 2023 and has been completed with Zero observation.

Shares of Gland Pharma Limited was last trading in BSE at Rs. 1341.55 as compared to the previous close of Rs. 1357.00. The total number of shares traded during the day was 221698 in over 9951 trades.

The stock hit an intraday high of Rs. 1452.80 and intraday low of 1330.00. The net turnover during the day was Rs. 303701237.00.

Source : Equity Bulls

Keywords

GlandPharma INE068V01023 USFDA Inspection ZeroObservation APIFacility JNPC Visakhapatnam